Oxidative stress-dependent cyclooxygenase-2-derived prostaglandin F 2α impairs endothelial function in renovascular hypertensive rats

Antioxidants and Redox Signaling

Volumn 16, Issue 4, 2012, Pages 363-373

  Tian, Xiao Yu ^a   Wong, Wing Tak ^a,b   Leung, Fung Ping ^a   Zhang, Yang ^a   Wang, Yi Xiang ^a   Lee, Hung Kay ^a   Ng, Chi Fai ^a   Chen, Zhen Yu ^a   Yao, Xiaoqiang ^a   Au, Chak Leung ^a   Lau, Chi Wai ^a   Vanhoutte, Paul M ^c   Cooke, John P ^b   Huang, Yu ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; BONE MORPHOGENETIC PROTEIN 4; CELECOXIB; CYCLOOXYGENASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN F2 ALPHA; REACTIVE OXYGEN METABOLITE; SCAVENGER; TEMPOL; TERUTROBAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM DEPENDENT RELAXATION; ENZYME PHOSPHORYLATION; KIDNEY ARTERY STENOSIS; KIDNEY BLOOD FLOW; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL ARTERY; RENOVASCULAR HYPERTENSION; UPREGULATION; VASOCONSTRICTION; VASODILATATION;

ANIMALS; CYCLOOXYGENASE 2; DINOPROST; ENDOTHELIUM, VASCULAR; HYPERTENSION, RENOVASCULAR; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84855392271     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3874     Document Type: Article

References (48)

1. Adeagbo AS, Zhang X, Patel D, Joshua IG, Wang Y, Sun X, Igbo IN, and Oriowo MA. Cyclo-oxygenase-2, endothelium and aortic reactivity during deoxycorticosterone acetate saltinduced hypertension. J Hypertens 23: 1025-1036, 2005. (Pubitemid 40637922)
2. Auch-Schwelk W, Katusic ZS, and Vanhoutte PM. Thromboxane A2 receptor antagonists inhibit endothelium-dependent contractions. Hypertension 15: 699-703, 1990. (Pubitemid 20189444)
3. Camacho M, Lopez-Belmonte J, and Vila L. Rate of vasoconstrictor prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and prostaglandin I synthase activity. Circ Res 83: 353-365, 1998. (Pubitemid 28389965)
4. Castro MM, Rizzi E, Rodrigues GJ, Ceron CS, Bendhack LM, Gerlach RF, and Tanus-Santos JE. Antioxidant treatment reduces matrix metalloproteinase-2- induced vascular changes in renovascular hypertension. Free Radic Biol Med 46: 1298-1307, 2009.
5. Chenevard R, Hurlimann D, Bechir M, Enseleit F, Spieker L, Hermann M, Riesen W, Gay S, Gay RE, Neidhart M, Michel B, Luscher TF, Noll G, and Ruschitzka F. Selective COX-2 inhibition improves endothelial function in coronary artery disease. Circulation 107: 405-409, 2003.
6. Csiszar A, Smith KE, Koller A, Kaley G, Edwards JG, and Ungvari Z. Regulation of bone morphogenetic protein-2 expression in endothelial cells: role of nuclear factor-kappaB activation by tumor necrosis factor-alpha, H2O2, and high intravascular pressure. Circulation 111: 2364-2372, 2005. (Pubitemid 40655331)
7. Dohi Y, Criscione L, and Luscher TF. Renovascular hypertension impairs formation of endothelium-derived relaxing factors and sensitivity to endothelin-1 in resistance arteries. Br J Pharmacol 104: 349-354, 1991.
8. Eligini S, Barbieri SS, Cavalca V, Camera M, Brambilla M, De Franceschi M, Tremoli E, and Colli S. Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-alpha and phorbol ester in human endothelial cells. Cardiovasc Res 65: 683-693, 2005. (Pubitemid 40138989)
9. Flavahan NA. Balancing prostanoid activity in the human vascular system. Trends Pharmacol Sci 28: 106-110, 2007. (Pubitemid 46283588)
10. Fortes ZB, Costa SG, Nigro D, Scivoletto R, de Oliveira MA, and de Carvalho MH. Effect of indomethacin on the microvessel reactivity of two-kidney, one-clip hypertensive rats. Arch Int Pharmacodyn Ther 316: 75-89, 1992.
11. Galli SM and Phillips MI. Angiotensin II AT(1A) receptor antisense lowers blood pressure in acute 2-kidney, 1-clip hypertension. Hypertension 38: 674-678, 2001.
12. Garcia-Saura MF, Galisteo M, Villar IC, Bermejo A, Zarzuelo A, Vargas F, and Duarte J. Effects of chronic quercetin treatment in experimental renovascular hypertension. Mol Cell Biochem 270: 147-155, 2005. (Pubitemid 40425245)
13. Ge T, Hughes H, Junquero DC, Wu KK, Vanhoutte PM, and Boulanger CM. Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H synthase-1 and hypersensitivity to prostaglandin H2 in the SHR aorta. Circ Res 76: 1003-1010, 1995.
14. Gluais P, Lonchampt M, Morrow JD, Vanhoutte PM, and Feletou M. Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin. Br J Pharmacol 146: 834-845, 2005. (Pubitemid 41622250)
15. Goldblatt H, Lynch J, Hanzal RF, and Summerville WW. Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 59: 347-379, 1934.
16. Griffith JF, Wang YX, Zhou H, Kwong WH, Wong WT, Sun YL, Huang Y, Yeung DK, Qin L, and Ahuja AT. Reduced bone perfusion in osteoporosis: likely causes in an ovariectomy rat model. Radiology 254: 739-746, 2010.
17. Grote K, Ortmann M, Salguero G, Doerries C, Landmesser U, Luchtefeld M, Brandes RP, Gwinner W, Tschernig T, Brabant EG, Klos A, Schaefer A, Drexler H, and Schieffer B. Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation. Cardiovasc Res 71: 596-605, 2006. (Pubitemid 44107869)
18. Hanna IR, Taniyama Y, Szocs K, Rocic P, and Griendling KK. NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 4: 899-914, 2002. (Pubitemid 36042466)
19. Heitzer T, Wenzel U, Hink U, Krollner D, Skatchkov M, Stahl RA, MacHarzina R, Brasen JH, Meinertz T, and Munzel T. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int 55: 252-260, 1999. (Pubitemid 29004257)
20. Higashi Y, Oshima T, Sasaki S, Nakano Y, Kambe M, Matsuura H, and Kajiyama G. Angiotensin-converting enzyme inhibition, but not calcium antagonism, improves a response of the renal vasculature to L-arginine in patients with essential hypertension. Hypertension 32: 16-24, 1998. (Pubitemid 28324119)
21. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, and Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 346: 1954-1962, 2002. (Pubitemid 34651355)
22. Hirao A, Kondo K, Takeuchi K, Inui N, Umemura K, Ohashi K, and Watanabe H. Cyclooxygenase-dependent vasoconstricting factor(s) in remodelled rat femoral arteries. Cardiovasc Res 79: 161-168, 2008. (Pubitemid 351881948)
23. Jung O, Schreiber JG, Geiger H, Pedrazzini T, Busse R, and Brandes RP. gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation 109: 1795-1801, 2004. (Pubitemid 38500684)
24. Karim S, Habib A, Levy-Toledano S, and Maclouf J. Cyclooxygenase-1 and-2 of endothelial cells utilize exogenous or endogenous arachidonic acid for transcellular production of thromboxane. J Biol Chem 271: 12042-12048, 1996. (Pubitemid 26157282)
25. Katusic ZS, Schugel J, Cosentino F, and Vanhoutte PM. Endothelium-dependent contractions to oxygen-derived free radicals in the canine basilar artery. Am J Physiol 264: H859-H864, 1993. (Pubitemid 23109879)
26. Lerman LO, Nath KA, Rodriguez-Porcel M, Krier JD, Schwartz RS, Napoli C, and Romero JC. Increased oxidative stress in experimental renovascular hypertension. Hypertension 37: 541-546, 2001. (Pubitemid 32199025)
27. Leung FP, Yao X, Lau CW, Ko WH, Lu L, and Huang Y. Raloxifene relaxes rat intrarenal arteries by inhibiting Ca2 + influx. Am J Physiol Renal Physiol 289: F137-F144, 2005. (Pubitemid 40863581)
28. Lockette W, Otsuka Y, and Carretero O. The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 8: II61-II66, 1986.
29. Maloney E, Sweet IR, Hockenbery DM, Pham M, Rizzo NO, Tateya S, Handa P, Schwartz MW, and Kim F. Activation of NF-kappaB by palmitate in endothelial cells: a key role for NADPH oxidase-derived superoxide in response to TLR4 activation. Arterioscler Thromb Vasc Biol 29: 1370-1375, 2009.
30. Miller FJ, Jr., Gutterman DD, Rios CD, Heistad DD, and Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 82: 1298-1305, 1998. (Pubitemid 28294749)
31. Miriyala S, Gongora Nieto MC, Mingone C, Smith D, Dikalov S, Harrison DG, and Jo H. Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation. Circulation 113: 2818-2825, 2006. (Pubitemid 44305294)
32. Rees D, Ben-Ishay D, and Moncada S. Nitric oxide and the regulation of blood pressure in the hypertension-prone and hypertension-resistant Sabra rat. Hypertension 28: 367-371, 1996. (Pubitemid 26296036)
33. San Martin A, Du P, Dikalova A, Lassegue B, Aleman M, Gongora MC, Brown K, Joseph G, Harrison DG, Taylor WR, Jo H, and Griendling KK. Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes. Am J Physiol Heart Circ Physiol 292: H2073-H2082, 2007. (Pubitemid 47084581)
34. Sheu ML, Chiang CK, Tsai KS, Ho FM, Weng TI, Wu HY, and Liu SH. Inhibition of NADPH oxidase-related oxidative stress-triggered signaling by honokiol suppresses high glucose-induced human endothelial cell apoptosis. Free Radic Biol Med 44: 2043-2050, 2008.
35. Stankevicius E, Martinez AC, Mulvany MJ, and Simonsen U. Bluntedacetylcholine relaxationandnitric oxide release inarteries from renal hypertensive rats. J Hypertens 20: 1571-1579, 2002. (Pubitemid 34921181)
36. Textor SC and Wilcox CS. Renal artery stenosis: a common, treatable cause of renal failure?Annu RevMed 52: 421-442, 2001. (Pubitemid 32195333)
37. Thomas SR, Witting PK, and Drummond GR. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal 10: 1713-1765, 2008.
38. Tian J, Wong WT, Tian XY, Zhang P, Huang Y, and Wang N. Rosiglitazone attenuates endothelin-1-induced vasoconstriction by upregulating endothelial expression of endothelin B receptor. Hypertension 56: 129-135, 2010.
39. Virdis A, Colucci R, Fornai M, Duranti E, Giannarelli C, Bernardini N, Segnani C, Ippolito C, Antonioli L, Blandizzi C, Taddei S, Salvetti A, and Del Tacca M. Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infusedmice. Hypertension 49: 679-686, 2007.
40. Virdis A, Colucci R, Versari D, Ghisu N, Fornai M, Antonioli L, Duranti E, Daghini E, Giannarelli C, Blandizzi C, Taddei S, and Del Tacca M. Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats: role of cyclooxygenase 2-derived contracting prostanoids. Hypertension 53: 1008-1016, 2009.
41. Widlansky ME, Price DT, Gokce N, Eberhardt RT, Duffy SJ, Holbrook M, Maxwell C, Palmisano J, Keaney JF, Jr., Morrow JD, and Vita JA. Short-and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension. Hypertension 42: 310-315, 2003. (Pubitemid 37093478)
42. Wong WT, Tian XY, Chen Y, Leung FP, Liu L, Lee HK, Ng CF, Xu A, Yao X, Vanhoutte PM, Tipoe GL, and Huang Y. Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: implications on hypertension. Circ Res 107: 984-991, 2010.
43. Wong WT, Tian XY, Xu A, Ng CF, Lee HK, Chen ZY, Au CL, Yao X, and Huang Y. Angiotensin II type 1 receptordependent oxidative stress mediates endothelial dysfunction in type 2 diabetic mice. Antioxid Redox Signal 13: 757-768, 2010.
44. Yang D, Feletou M, Boulanger CM, Wu HF, Levens N, Zhang JN, and Vanhoutte PM. Oxygen-derived free radicals mediate endothelium-dependent contractions to acetylcholine in aortas from spontaneously hypertensive rats. Br J Pharmacol 136: 104-110, 2002. (Pubitemid 34499322)
45. Yang D, Levens N, Zhang JN, Vanhoutte PM, and Feletou M. Specific potentiation of endothelium-dependent contractions in SHR by tetrahydrobiopterin. Hypertension 41: 136-142, 2003. (Pubitemid 36056805)
46. Yogi A, Callera GE, Hipolito UV, Silva CR, Touyz RM, and Tirapelli CR. Ethanol-induced vasoconstriction is mediated via redox-sensitive cyclo-oxygenase-dependent mechanisms. Clin Sci (Lond) 118: 657-668, 2010.
47. Yu Y, Lucitt MB, Stubbe J, Cheng Y, Friis UG, Hansen PB, Jensen BL, Smyth EM, and FitzGerald GA. Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis. Proc Natl Acad Sci USA 106: 7985-7990, 2009.
48. Zou MH, Shi C, and Cohen RA. High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H(2) receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes 51: 198-203, 2002. (Pubitemid 34517998)